Clinical trials

36

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Suzetrigine in Total Hip Arthroplasty

Total hip and knee joint replacements are among the most common and painful orthopedic procedures performed worldwide, often requiring intensive analgesia to support early ambulation and recovery. Despite widespread use of multimodal regimens, many patients still rely on opioids, which can cause sedation, nausea, constipation, and long-term dependency. Evaluating Suzetrigine in this high-need population may improve recovery trajectories, reduce opioid consumption, and support enhanced recovery protocols. Given the growing surgical volume and the emphasis on opioid-sparing strategies, rigorous investigation of Suzetrigine's efficacy in joint replacement is of high clinical value. In this study, patients undergoing primary total hip replacement will be randomized to receive either Suzetrigine or placebo for seven days, with the loading dose administered prior to surgery. The primary outcome is cumulative 48-hour opioid consumption in oral morphine equivalents starting from entry into the post-anesthesia care unit (PACU).

Participants needed: 210
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Jun 3, 2026Locations: 1
Eligibility criteria

Patients undergoing primary THA (posterior approach) with participating surgeons [+4]

ASA greater than 3 [+12]

Status: Available

Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint

The purpose of this study is to allow patients to undergo surgery with the SR™ PIP (Proximal Interphalangeal) Implants for finger arthritis. This is NOT a research study, but rather, a requirement by the FDA for humanitarian use of device

Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: Hospital for Special Surgery, New YorkUpdated: May 14, 2026Locations: 1
Eligibility criteria

patient is in need of a revision of failed PIP prosthesis(es) [+1]

patient is not in need of a revision of a failed PIP prothesis(es) [+1]

Status: Recruiting

Cervical Radiculopathy Imaging Using MRN With Electrodiagnostic Correlation

This project will study patients with cervical radiculopathy. We will evaluate the combined diagnostic and prognostic value of magnetic resonance neurography (MRN), electrodiagnostic (EDX) studies, and historical and physical clinical elements. Specifically, this project will explore whether these data individually or in combination correlate with response to procedural and non-procedural treatment.

Participants needed: 20
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 27, 2026Locations: 1
Eligibility criteria

Patients presenting with symptoms compatible with acute or subacute unilateral (... [+4]

Prior cervical surgery or instrumentation [+5]

Status: Not yet recruiting

DEI Education in Anesthesiology

To date, there has not been an assessment of ASA members to determine satisfaction with DEI and cultural humility/structural competency education within institutions and programs. We developed a 24-question survey that will be distributed via email to current members of the American Society of Anesthesiologists. Members include learners at all levels - medical students, residents and fellows - as well as attending anesthesiologists, CRNAs, research staff etc. The survey questions are aimed to assess the current state of diversity training in anesthesiology education. This survey serves as a needs assessment and will help gather information on the current state of DEI education within the specialty. The results of the survey will serve as an impetus for improvement in this domain by developing novel educational modules and workshops on these topics, at the institutional level and nationwide.

Participants needed: 3,000
Trial details
Biological sex: AllType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 27, 2026
Eligibility criteria

American Society of Anesthesiologist Member

Not a member of the American Society of Anesthesiologists

Status: Recruiting

Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy

This study will examine whether using bone marrow aspirate (BMA) during knee arthroscopy surgery can improve patient outcomes. The investigators will enroll 50 patients who need knee arthroscopy surgery for meniscus injuries or cartilage damage. Like flipping a coin, patients will be randomly assigned to one of two groups of 25 patients each. One group will receive standard arthroscopic surgery plus an injection of bone marrow aspirate, while the other group will receive standard surgery plus a saline (salt water) injection. During surgery, for patients in the treatment group, approximately 4mL (less than one teaspoon) of bone marrow will be taken from their hip bone using a special needle system. A small amount (1mL) will be sent to the laboratory for testing. Patients will be followed for 12 months after surgery and will complete questionnaires about their pain levels and knee function at several time points: before surgery, 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after surgery. These questionnaires will ask about pain, daily activities, and overall improvement.

Participants needed: 50
Trial details
Age: 18-64Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 27, 2026Locations: 1
Eligibility criteria

Require a primary knee arthroscopy for a meniscal injury or focal chondral defec... [+3]

Have previously undergone ipsilateral knee surgery [+9]

Status: Not yet recruiting

Fiber Smoothie Supplement

This study aims to assess the feasibility of a 2-week dietary whole-food smoothie intervention and compare outcomes between two groups: patients that integrated a daily whole food plant-based smoothie into their diet for two weeks prior to surgery, and a control group of revision TKA patients that made no nutritional changes to their diet prior to surgery. The main research questions are: 1. Among patients planned for elective TKA revision surgery, what is the feasibility of a 2-week dietary intervention implemented 2 weeks prior to surgery? \[Outcomes will be compliance, noted barriers and/or facilitators, satisfaction with diet\] 2. Determine if the implementation of a daily whole food plant- based smoothie dietary supplement 2 weeks prior to TKA revision surgery will reduce inflammation -measured in plasma levels of IL-6 and CRP- at POD0, POD1, POD2, POD3, and 6 Weeks Post-operative as compared to 1) baseline (prior to dietary intervention initiation) and 2) control patients who did not make changes in their diet prior to surgery. 3. Determine if the implementation of a daily whole food plant-based smoothie dietary supplement 2 weeks prior to TKA revision surgery will result in quantifiable changes in the gut microbiome composition -measured via fecal samples- as compared to control patients who did not make changes in their diet prior to surgery. 4. Determine if the implementation of a daily whole food plant- based smoothie dietary supplement 2 weeks prior to TKA revision surgery will result in improved immediate postoperative pain -measured through numeric rating scale (NRS) pain scores- and opioid use -measured in morphine milligram equivalents (MME)- as compared to control patients. 5. Compare patient satisfaction and adoption of nutritional behavioral changes in patients implementing a whole food plant-based smoothie 2 weeks prior to TKA revision surgery to patients undergoing the same surgery but did not me pre-surgery dietary changes. The researcher's primary outcome is measuring feasibility and patient compliance with smoothie consumption. Secondarily, the investigators are interested in measuring if the preoperative smoothie can alter the gut microbiome and decrease systemic inflammation, leading to lowered post-operative pain and opioid use.

Participants needed: 24
Trial details
Age: 40-80Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Scheduled for revision TKA at HSS with participating surgeons; not as a result o... [+25]

Status: Recruiting

Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.

Participants needed: 150
Trial details
Phase: Phase 3Age: 18-85Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Patients scheduled to undergo 1 to 2 level laminectomy [+1]

Minimally invasive surgery [+5]

Status: Recruiting

Categorized PT for Non-arthritic Hip and Groin Pain

There is currently limited literature on a categorized physical therapy protocol for management of hip pain. Only a handful of studies have looked at the treatment of osteoarthritis of the hip with a standardized physical therapy treatment, primarily looking at manual therapy versus exercise therapy protocols. However, there are no studies observing the effect of a standardized physical therapy program on patients presenting with non-arthritic hip and groin pain. Based on the gap in the literature, this study will aim to assess the effect of matrix-based standard of care therapy in patients presenting with non-arthritic hip and groin pain.

Participants needed: 70
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

New patient presenting with non-arthritic hip impingement, hip pain, and groin p... [+1]

Arthritic hip pain (Tonnis 2+) [+8]

Status: Recruiting

Effects of Bisphosphonates on OI-Related Hearing Loss

Osteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, with the majority of individuals experiencing some minor hearing loss in their 20s. Bisphosphonates have been successfully used to treat otosclerosis, a common cause of hearing loss similar to OI-related hearing loss. As many individuals with OI-related hearing loss also present with otosclerosis and because of their mechanistic similarities, the investigators propose studying the effects of bisphosphonate treatment on individuals diagnosed with both OI type I and hearing loss, thereby determining its effectiveness as a potential treatment for hearing loss. The investigators will enroll 50 individuals diagnosed with type I OI and age 18-100. 25 adults will be enrolled into the treatment arm and receive bisphosphonate treatment (must have at least mild hearing loss), while 25 adults will be enrolled into the control arm. The investigators will enroll 25 children (6-17 years of age) diagnosed with OI who are currently receiving bisphosphonate treatment as part of their care for orthopedic symptoms. The investigators will also observe 25 children (6-17 years of age) diagnosed with OI who are NOT currently receiving bisphosphonate treatment. The study duration is 63 months (approximately 5 years). Enrollment is anticipated to begin in November 2019.

Participants needed: 100
Trial details
Phase: Phase 4Age: 6-100Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Diagnosis of OI type I [+10]

Family history of hearing-loss (not related to OI or occupational hearing loss) [+1]

Status: Recruiting

Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

A comparison of two anesthetic techniques for total knee replacements: (1) Peri-Articular Injection (PAI), local infiltration between the popliteal artery and capsule of the knee block (IPACK) and single-shot adductor canal block (ACB) vs. (2) PAI, IPACK and continuous adductor canal block catheter (ACC).

Participants needed: 94
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Patients with osteoarthritis scheduled for a primary total knee arthroplasty wit... [+5]

Hepatic or renal insufficiency [+13]

Status: Recruiting

Tranexamic Acid in Adult Spinal Deformity Surgery

Posterior spinal surgery for adult deformity is associated with high incidence of blood loss and need for blood transfusion and intraoperative blood salvage, with associated increased cost and risk for perioperative complications. Tranexamic acid (TXA) is relatively inexpensive anti-fibrinolytic agent that has been proven effective for decreasing intraoperative blood loss in various surgical specialties. Intravenous TXA (ivTXA) is routinely used at our institution for adult spinal deformity cases. Meanwhile, topical TXA (tTXA) is an attractive alternative/adjunct to ivTXA used with good results in orthopedic arthroplasty and cardiac surgery. To the investigators' knowledge, no data exists in the literature on the use of tTXA in either adult or pediatric spinal deformity surgery. The goal of this study is to determine the role tTXA has an adjunct to ivTXA in decreasing perioperative blood loss, drainage, transfusion requirements and length of stay following adult deformity spine surgery.

Participants needed: 100
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Age 18-80 [+2]

Anterior Approach [+16]

Status: Recruiting

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

The PROMISSE Study is an observational study of 700 pregnant patients, enrolled at nine major clinical centers. The purpose of the study is 1) to determine whether certain proteins (called complement split products) that can injure healthy organs can be used to predict poor pregnancy outcome in patients with systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS), and/or 2) to determine whether elevated levels of circulating antiangiogenic factors predict pregnancy complications in patients with aPL antibodies and/or SLE.

Participants needed: 700
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 28, 2026Locations: 10
Eligibility criteria

Patient pregnant with live intrauterine pregnancy, as defined by positive test f... [+11]

Diabetes mellitus (Type I and Type II) antedating pregnancy [+1]

Status: Recruiting

Does Joint Immobilization Following Revision Total Knee Arthroplasty Improve Range of Motion Following Surgery?

The goal of this study is to evaluate if knee immobilization for 10 days following revision total knee arthroplasty (rTKA) improves knee joint range of motion at 3 months postoperatively compared to standard of care postoperative protocol. Participants will be assigned to one of two groups. One group will wear a knee brace that keeps the knee straight for 10 days after surgery and will not perform knee range of motion exercises during that time. The other group will not wear a brace and will follow the standard physical therapy program, including knee range of motion exercises, starting after surgery.

Participants needed: 170
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 27, 2026Locations: 1
Eligibility criteria

Patients undergoing revision TKA for aseptic indications including aseptic loose... [+1]

Patients who are undergoing revision TKA for stiffness. [+7]

Status: Recruiting

Preoperative Oral Hydration in the Ambulatory Arthroplasty Population

The purpose of this study is to investigate if the consumption of a complex carbohydrate drink preoperatively, decreases the length of stay and causes for failure to launch in patients undergoing ambulatory total joint arthroplasty.

Participants needed: 312
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 13, 2026Locations: 1
Eligibility criteria

Candidates for ambulatory total knee arthroplasty [+5]

BMI less than 18.5 or greater than 37.0 [+4]

Status: Recruiting

Comparing Original Patient Educational Materials vs. AI-Simplified Materials to Improve Patient Comprehension and Health Literacy

Poor health literacy and patient comprehension have been associated with adverse health outcomes. Patient educational materials (PEMs) are articles that are intended to assist patients in their understanding of a given medical condition. Given that the average American adult reads at the 8th grade level, the American Medical Association and the Center for Disease Control recommend PEM be written at the 6th grade level. However, literature has found the majority of PEMs to be written significantly higher than the 8th grade level. In order to improve their readability, a number of studies have displayed the effectiveness of large language models (LLMs) such as ChatGPT to simplify the text of a given PEM. Despite the improvement in readability, the effectiveness of these simplified PEMs on improving patient comprehension of the AI augmented material has yet to be investigated. The purpose of our study is to test whether the improvement in readability found in AI-simplified PEMs corresponds to a greater understanding of the material compared to the original PEM. Understanding if AI-simplified PEM truly improves comprehension could further support this use case for AI and aid providers and healthcare organizations in improving the health literacy of their patients. This study aims to answer the following question: Do AI simplified PEMs improve the comprehension of pediatric orthopaedic conditions? Researchers will compare AI-simplified PEMs to their original, unmodified counterparts in order to see if there is any difference in post reading comprehension of the participants. Participation in the study will include: * A brief baseline survey (e.g. demographics and educational attainment) * A randomly assigned reading of either the original PEM or the AI simplified version. * A 10 question post-reading multiple choice quiz

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Apr 3, 2026Locations: 1
Eligibility criteria

Parents or guardians of pediatric patients receiving treatment at Hospital for S...

Non-English Speaking [+2]

Status: Recruiting

Early Versus Delayed Bathing of Orthopaedic Surgical Wounds

This is a single center randomized control trial assessing the effect of early versus delayed bathing on orthopaedic surgical wounds in patients undergoing surgical treatment of fractures. Patients will be recruited by screening all patients undergoing surgical treatment for fractures at our institution. Patients who provide written consent will be randomized to one of two treatment arms after confirming eligibility criteria. Group A will be advised to begin early normal bathing (non-submerged showering) with uncovered surgical wounds. Group B will be advised to follow traditional delayed bathing with covered wounds. Those who do not wish to participate in the randomized trial will be invited to participate observationally (no randomization) and have the same prospective follow-up.

Participants needed: 56
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Patients over 18 years of age [+5]

Fractures associated with presumed infection [+8]

Status: Recruiting

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

This is a 52 week, single center, randomized, double-blind, placebo-controlled study. After patients maintain a stable dose of Mycophenolate Mofetil (MMF) for at least 1 month, they will be randomized to treatment with either Belimumab \& Rituximab or placebo.Patients in both groups will be on background MMF for the entirety of the study. Belimumab will be administered subcutaneously and Rituximab intravenously. Placebo injections and infusions will be of normal saline. Randomization will be done in a 2:1 manner to favor the treatment group. It is hypothesized that that Rituximab and Belimumab combination therapy with Mycophenolate Mofetil background therapy will improve fibrosis in SSc skin when compared to treatment with placebo and Mycophenolate Mofetil in a group of patients with early dcSSc.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Age greater than or equal to eighteen years and less than or equal to 80. [+4]

Inability to render informed consent in accordance with institutional guidelines... [+19]

Status: Recruiting

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

The goal of this observational study is to learn about the outcomes of medial patellofemoral ligament (MPFL) reconstruction for the treatment of recurrent patellar instability. The main questions it aims to answer are: * What are the risk factors for recurrent patellar instability after MPFL reconstruction? * What functional outcomes do patients report after MPFL reconstruction? Participants undergoing MPFL reconstruction will answer survey questions about their knee and activity level 1 year and 2 years after surgery.

Participants needed: 850
Trial details
Age: 10-35Biological sex: AllType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Feb 13, 2026Locations: 16
Eligibility criteria

10-35 years old [+1]

Previous ipsilateral knee surgery [+3]

Status: Recruiting

Post-Operative Thoracolumosacral Orthosis for PJK

Proximal junctional kyphosis (PJK) is a common post-operative radiographic finding after surgery for adult spinal deformity (ASD) patients. Although the clinical relevance of isolated PJK is unclear, PJK can progress to symptomatic proximal junctional failures which requires a large revision surgery. Currently, post-operative bracing with a thoracolumbosacral orthosis (TLSO) is common practice after spinal deformity surgery, however the efficacy of this in preventing PJK is unknown. This multi-center randomized control trial identified 84 patients undergoing thoracolumbosacral fusion for ASD and plans to study the efficacy of a novel post-operative TLSO in preventing the development of PJK as defined by the proximal junctional angle on 6-month post-operative X-rays.

Participants needed: 84
Trial details
Phase: Phase 4Age: 30-75Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Feb 13, 2026Locations: 6
Eligibility criteria

30-75-years-old [+1]

Osteoporosis (defined as a T-score <-2.5 at the time of surgery) [+5]

Status: Recruiting

Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis

The condition that will be studied is Rheumatoid Arthritis (RA), and in particular, RA patients with moderate to highly active disease who were prescribed Abatacept (Orencia®) (ABA) by their physician during their setting of care at Hospital for Special Surgery (HSS). This investigator-initiated, prospective, comparative, 3-arm observational study will examine changes in lymphocytes in RA patients starting abatacept compared to RA patients starting TNF inhibitors and to healthy controls. This will help investigators to learn more about the processes that cause joints to swell and hurt. This may also offer clues that might predict which patients will have a good or poor response to these treatments.

Participants needed: 72
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Feb 13, 2026Locations: 1
Eligibility criteria

Have severe complications of RA that might require imminent escalation of therap... [+10]

Status: Recruiting

Return to Golf After Orthopaedic Surgery

The GOLF study is a multicenter, prospective study with the goal to investigate golfers' return to the sport following hip, knee or shoulder arthroplasty. The prevalence of return to golf, by level of returning to golf will be assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Patients who are active golfers undergoing joint replacement will be identified from outpatient clinics and pre-assessment clinics and given information about the study at least two weeks prior to surgery. Participants in this study must have a desire to return to golf after surgery. Previous studies have only been able to report the return to golf after arthroplasty retrospectively; the prospective nature of this study will allow for a greater understanding of this process.

Participants needed: 432
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Feb 13, 2026Locations: 2
Eligibility criteria

Age 18+ years [+3]

Inability to complete follow-up questionnaires [+3]

Status: Recruiting

PRP in ACLR to Prevent PTOA

The purpose of our study is to examine the effect of platelet-rich-plasma (PRP) injection on the short-term resolution of post-injury inflammation (biomarkers) and improvement in joint function in patients with acute ACL injury. This RCT has been powered based on the questionnaire KOOS Jr. but it is considered a 'pilot study' in terms of the lab analysis proposed.

Participants needed: 56
Trial details
Phase: Phase 3Age: 14-50Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Feb 13, 2026Locations: 1
Eligibility criteria

Acute ACL injury within 6 weeks of presentation [+3]

Prior ACL reconstruction [+8]

Status: Recruiting

Undifferentiated Connective Tissue Disease Registry

This registry has been established to gain a better understanding of the clinical and emotional presentations of patients with undifferentiated connective tissue disease.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Feb 12, 2026Locations: 1Duration: 3 Years
Eligibility criteria

Any patient under the care of an HSS rheumatologist [+2]

Patients who meet criteria for well defined CTD including SLE, rheumatoid arthri... [+2]

Status: Recruiting

Hospital for Special Surgery Shoulder Arthroplasty Cohort

Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes. HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here. The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Hospital for Special Surgery, New YorkUpdated: Feb 12, 2026Locations: 2
Eligibility criteria

18 years or older and undergoing total shoulder arthroplasty at HSS

No other exclusion criteria. Pregnant women are eligible for the registry as thi...

Status: Recruiting

Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty

The goal of this interventional clinical trial is to assess opioid consumption 24-48 hrs post anesthesia block among patients undergoing total knee arthroplasty. The main question it aims to answer is: 1\. Is there a difference in opioid consumption 24-48 hours post block administration among patients that receive an adductor canal catheter (ACC) versus adductor canal block (ACB)? Participants will be: * Randomized to receive an adductor canal catheter (ACC) or a sham adductor canal catheter. * Asked to use the Diagnotes application to communicate with the pain doctor while the catheter is in place. * Follow up for up to 6 months post-operation. Researchers will compare the interventional group (ACC) to the control group (sham ACC + ACB) to see if there is difference in opioid consumption and chronic pain at 6 months post-operation.

Participants needed: 64
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Hospital for Special Surgery, New YorkUpdated: Jan 15, 2026Locations: 1
Eligibility criteria

Patients with osteoarthritis scheduled for a primary total knee arthroplasty wit... [+7]

Hepatic or renal insufficiency [+13]